Intuitive Surgical, Inc. (ISRG)
- Previous Close
372.63 - Open
385.27 - Bid 366.06 x 100
- Ask 366.42 x 100
- Day's Range
364.17 - 388.65 - 52 Week Range
254.85 - 403.76 - Volume
3,966,499 - Avg. Volume
1,631,634 - Market Cap (intraday)
129.943B - Beta (5Y Monthly) --
- PE Ratio (TTM)
66.25 - EPS (TTM)
5.53 - Earnings Date Jul 18, 2024 - Jul 22, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
414.80
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
www.intuitive.com13,676
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ISRG
Performance Overview: ISRG
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ISRG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ISRG
Valuation Measures
Market Cap
129.94B
Enterprise Value
125.14B
Trailing P/E
66.13
Forward P/E
58.82
PEG Ratio (5yr expected)
6.79
Price/Sales (ttm)
17.95
Price/Book (mrq)
9.31
Enterprise Value/Revenue
17.57
Enterprise Value/EBITDA
57.18
Financial Highlights
Profitability and Income Statement
Profit Margin
27.16%
Return on Assets (ttm)
8.00%
Return on Equity (ttm)
15.82%
Revenue (ttm)
7.32B
Net Income Avi to Common (ttm)
1.99B
Diluted EPS (ttm)
5.53
Balance Sheet and Cash Flow
Total Cash (mrq)
7.32B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: ISRG
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: ISRG
Analyst Report: Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
RatingBearishPrice TargetAnalyst Report: Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
RatingBearishPrice TargetAnalyst Report: Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
RatingBearishPrice TargetWeekly Stock List
We see what we believe are some great opportunities right now in Healthcare -- and we like the sector overall. Argus Director of Research Jim Kelleher, CFA, recently completed his quarterly sector review and raised Healthcare sector to Over-Weight from Market-Weight. The healthcare environment is undergoing rapid transitions, and we now see an unfolding period of significant promise and opportunity. Our newly-favored stance is based on resumption of deferred medical procedures and significant new quality-of-life drugs and treatments. The category is broad and has underperformed the S&P 500 over the past year. The Healthcare sector ETF (XLV) is up 15% over the past year compared to a gain of 31% for the S&P 500. We see opportunity here to pick up some steady companies, with big brands and solid financials. These companies are science-focused and enhance lives. They are innovators. In our list this week, we look across several subsectors within the Healthcare sector and pull out some leaders we like. These stocks also are included in our Focus List and Model Portfolios, as noted below.